Korean Gene Therapies On Horizon, But Slow Regulatory Changes A Drag
While Korean companies are actively pursuing development of gene therapies, various regulatory restrictions at home are keeping them from speeding up development. But global development continues apace, with interim Phase III results for some expected later this year.